<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04960371</url>
  </required_header>
  <id_info>
    <org_study_id>M2018058</org_study_id>
    <nct_id>NCT04960371</nct_id>
  </id_info>
  <brief_title>Effects of Anxiety on Coronary Microcirculatory Function in Hypertensive Patients</brief_title>
  <official_title>Effects of Anxiety on Coronary Microcirculatory Function in Hypertensive Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University Third Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking University Third Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study assessed anxiety status and coronary flow reserve in hypertensive patients to&#xD;
      investigate the effects of anxiety on coronary microcirculatory function.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study assessed anxiety status and coronary flow reserve in hypertensive patients to&#xD;
      investigate the effects of anxiety on coronary microcirculatory function.The hypertensive&#xD;
      patients with chest pain for suspicious coronary heart disease were seriesly enrolled. All&#xD;
      the patients underwent coronary angiography or coronary CT angiography to exclude the&#xD;
      diagnosis of obstructive coronary artery disease . Coronary flow reserve (CFR) is an&#xD;
      integrated measure of flow through both the large epicardial arteries and the coronary&#xD;
      microcirculation. In the absence of obstructive stenosis of the epicardial arteries, CFR is&#xD;
      an indicator of coronary microcirculatory function，which can be assayed by Transthoracic&#xD;
      Doppler echocardiography. The symptoms of anxiety were measured with Self-rating Anxiety&#xD;
      Scale (SAS) . According to the SAS score,the patients were divided into anxiety group and&#xD;
      non-anxiety group.We assessed the association of anxiety with coronary microcirculatory&#xD;
      function.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 28, 2018</start_date>
  <completion_date type="Anticipated">December 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Coronary flow reserve</measure>
    <time_frame>baseline</time_frame>
    <description>Coronary flow reserve (CFR) is an integrated measure of flow through both the large epicardial arteries and the coronary microcirculation. In the absence of obstructive stenosis of the epicardial arteries, CFR is an index of coronary microcirculatory function.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Inflammatory mediators</measure>
    <time_frame>baseline</time_frame>
    <description>Inflammatory mediators were measured using Quantibody Human Immune Response Array.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Coronary Microvascular Disease</condition>
  <condition>Anxiety State</condition>
  <arm_group>
    <arm_group_label>anxiety group</arm_group_label>
    <description>the score of Self-rating Anxiety Scale greater than 50</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non-anxiety group</arm_group_label>
    <description>the score of Self-rating Anxiety Scale less than 50</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>coronary flow reserve (CFR)</intervention_name>
    <description>Coronary flow velocity profiles in the left anterior descending artery were obtained using colour-guided pulse wave Doppler. We measured peak diastolic coronary flow velocity of the diastolic coronary waveform at rest and after ATP infusion (140 µg/kg. min) for 2 min. The CFR was calculated as the ratio of hyperaemic peak diastolic velocity to resting baseline diastolic velocity. All patients abstained from caffeine-containing drinks for at least 24h before testing.</description>
    <arm_group_label>anxiety group</arm_group_label>
    <arm_group_label>non-anxiety group</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      The serum sample&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The hypertensive patients with chest pain for suspicious coronary heart disease (CHD) in&#xD;
        Peking University Third Hospital were seriesly enrolled. All the patients underwent&#xD;
        coronary angiography or coronary CT angiography to exclude the diagnosis of OCAD.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients with clear diagnosis of hypertension (≥1 year, drug control within&#xD;
             140/90mmHg); (2) Significant coronary artery stenosis was excluded by imaging within 1&#xD;
             year (≤50%); (3) Age between 18 and 80.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. CHD, heart valve disease, congenital heart disease, cardiomyopathy and pericardial&#xD;
             disease; (2) Left ventricular ejection fraction (LVEF) &lt;50%; (3) Increased markers of&#xD;
             myocardial injury; (4) Diabetes mellitus, connective tissue disease, chronic&#xD;
             obstructive pulmonary disease and malignant tumor; 5) Severe hepatic and renal&#xD;
             impairment (Cr ≥120 umol/L, ALT ≥120 umol/L); 6) Pregnant women.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lijun Guo</last_name>
    <role>Study Director</role>
    <affiliation>Peking University Third Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lijun Guo</last_name>
    <phone>+8682265018</phone>
    <email>guo_li_jun@126.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ying Li</last_name>
    <phone>18811735238</phone>
    <email>liying_winter@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Peking University Third Hospital</name>
      <address>
        <city>Beijing</city>
        <zip>100191</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ying Li</last_name>
      <phone>18811735238</phone>
      <email>liying_winter@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 4, 2021</study_first_submitted>
  <study_first_submitted_qc>July 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 13, 2021</study_first_posted>
  <last_update_submitted>July 4, 2021</last_update_submitted>
  <last_update_submitted_qc>July 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>anxiety</keyword>
  <keyword>coronary microcirculatory function</keyword>
  <keyword>hypertension</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Microvascular Angina</mesh_term>
    <mesh_term>Anxiety Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

